510 related articles for article (PubMed ID: 10359535)
81. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
[TBL] [Abstract][Full Text] [Related]
82. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
Puri PL; Balsano C; Burgio VL; Chirillo P; Natoli G; Ricci L; Mattei E; Graessmann A; Levrero M
Oncogene; 1997 Mar; 14(10):1171-84. PubMed ID: 9121766
[TBL] [Abstract][Full Text] [Related]
83. Interferon-alpha inhibits cyclin E- and cyclin D1-dependent CDK-2 kinase activity associated with RB protein and E2F in Daudi cells.
Zhang K; Kumar R
Biochem Biophys Res Commun; 1994 Apr; 200(1):522-8. PubMed ID: 8166726
[TBL] [Abstract][Full Text] [Related]
84. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro.
Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ
Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019
[TBL] [Abstract][Full Text] [Related]
85. Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins.
Gartel AL; Goufman E; Tevosian SG; Shih H; Yee AS; Tyner AL
Oncogene; 1998 Dec; 17(26):3463-9. PubMed ID: 10030670
[TBL] [Abstract][Full Text] [Related]
86. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I.
von Harsdorf R; Hauck L; Mehrhof F; Wegenka U; Cardoso MC; Dietz R
Circ Res; 1999 Jul; 85(2):128-36. PubMed ID: 10417394
[TBL] [Abstract][Full Text] [Related]
87. Radiation-induced cell cycle arrest compromised by p21 deficiency.
Brugarolas J; Chandrasekaran C; Gordon JI; Beach D; Jacks T; Hannon GJ
Nature; 1995 Oct; 377(6549):552-7. PubMed ID: 7566157
[TBL] [Abstract][Full Text] [Related]
88. Transcription factor E2F and cyclin E-Cdk2 complex cooperate to induce chromosomal DNA replication in Xenopus oocytes.
Akamatsu E; Tanaka T; Kato JY
J Biol Chem; 1998 Jun; 273(26):16494-500. PubMed ID: 9632717
[TBL] [Abstract][Full Text] [Related]
89. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
[TBL] [Abstract][Full Text] [Related]
90. The amino terminus of Cdk2 binds p21.
Moskowitz NK; Borao FJ; Dardashti O; Cohen HD; Germino FJ
Oncol Res; 1996; 8(9):343-52. PubMed ID: 8979268
[TBL] [Abstract][Full Text] [Related]
91. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein.
Campanero MR; Flemington EK
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2221-6. PubMed ID: 9122175
[TBL] [Abstract][Full Text] [Related]
92. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
Diehl JA; Zindy F; Sherr CJ
Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
[TBL] [Abstract][Full Text] [Related]
93. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
Hateboer G; Kerkhoven RM; Shvarts A; Bernards R; Beijersbergen RL
Genes Dev; 1996 Dec; 10(23):2960-70. PubMed ID: 8956997
[TBL] [Abstract][Full Text] [Related]
94. Interaction of human thymidine kinase 1 with p21(Waf1).
Huang DY; Chang ZF
Biochem J; 2001 Jun; 356(Pt 3):829-34. PubMed ID: 11389691
[TBL] [Abstract][Full Text] [Related]
95. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo.
Cooper MP; Balajee AS; Bohr VA
Mol Biol Cell; 1999 Jul; 10(7):2119-29. PubMed ID: 10397753
[TBL] [Abstract][Full Text] [Related]
96. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.
Hofmann F; Martelli F; Livingston DM; Wang Z
Genes Dev; 1996 Dec; 10(23):2949-59. PubMed ID: 8956996
[TBL] [Abstract][Full Text] [Related]
97. p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition.
Cazzalini O; Perucca P; Riva F; Stivala LA; Bianchi L; Vannini V; Ducommun B; Prosperi E
Cell Cycle; 2003; 2(6):596-603. PubMed ID: 14504476
[TBL] [Abstract][Full Text] [Related]
98. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
Leone G; DeGregori J; Jakoi L; Cook JG; Nevins JR
Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6626-31. PubMed ID: 10359762
[TBL] [Abstract][Full Text] [Related]
99. p21 is a universal inhibitor of cyclin kinases.
Xiong Y; Hannon GJ; Zhang H; Casso D; Kobayashi R; Beach D
Nature; 1993 Dec; 366(6456):701-4. PubMed ID: 8259214
[TBL] [Abstract][Full Text] [Related]
100. A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-cyclin A complex.
Devoto SH; Mudryj M; Pines J; Hunter T; Nevins JR
Cell; 1992 Jan; 68(1):167-76. PubMed ID: 1310073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
